MPA to lead European collaboration on drug effectiveness

Monday, February 01, 2010

During 2010, Medical Products Agency will be in head of a collaborative effort to improve the dissemination of knowledge about medicinal effects in clinical everyday life in Europe. The MPA will support networks within the EU as a successful working in the field of "drug effectiveness".

During the Swedish EU Presidency the Ministry of Health and Social Affairs, together with the MPA and the Swedish Pricing and Reimbursement Agency (TLV) arranged the conference ”Assessing Drug Effectiveness – Common Opportunities and Challenges for Europe”.

The conclusions from the conference emphasized the value of identifying clinical networks that perform innovative activities within this field.

The MPA has now taken on the task to form an Oversight Committee that will select a limited number of pilot projects in Europe, which are producing data of value for the assessment of drug effectiveness.

The focus will be on the improvement of generation, collecting and sharing of data that can be useful for the care of patients as well as for research, regulatory and industry purposes. The knowledge gained from the pilot projects will be disseminated from the Oversight Committee by the internet and meetings.



Please note the news item’s date of publishing. The Medical Products Agency does not update news.


Related information


Contact us

Nils Feltelius
Associate Professor
+46 18 17 46 30 (office)
+46 70 558 27 44 (mobile)


Medical Products Agency, P.O. Box 26, SE-751 03 Uppsala, SWEDEN | phone: +46 18 174600, fax: +46 18 548566 | Contact information